Bernie Sanders on insulin expenses and generic drug settlements

W ASHINGTON– Wednesday’s Senate hearing on high expenses for insulin “is not completion” of Sen. Bernie Sanders’ prepare for drug prices interrogations, he informed STAT in an interview. However it will be a program.

The Vermont independent is bringing executives from drugmakers Eli Lilly, Novo Nordisk and Sanofi, in addition to drug store advantage supervisors Express Scripts, OptumRx and CVS Health, to appear prior to the Senate Health, Education, Labor & & Pensions Committee today.

Open this post by registering for STAT+ and enjoy your very first thirty days complimentary!


Like this post? Please share to your friends:
Leave a Reply

;-) :| :x :twisted: :smile: :shock: :sad: :roll: :razz: :oops: :o :mrgreen: :lol: :idea: :grin: :evil: :cry: :cool: :arrow: :???: :?: :!: